Skip to content

Effects of Phlebotomy for the Japanese patients with NAFLD

Effects of Phlebotomy for the Japanese patients with NAFLD - Effects of Phlebotomy for the patients with NAFLD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014142
Enrollment
30
Registered
2014-06-04
Start date
2014-06-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD

Interventions

phlebotomy associated with dietary and lifestyle counseling removal of 400 mL(man) or 300 mL(woman) of blood at each biweekly or monthly session, depending on patient tolerance and availability, un

Sponsors

Osaka City Juso Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Non drinker (<20 g/day) 2. The patients who was excluded other chronic liver disease were excluded 3. The patients who diagnosed as fatty liver by abdominal CT or ultrasonography

Exclusion criteria

Exclusion criteria: 1. Serum ferritin < 20 ng/ml or Hb < 11 g/dl 2. Patients who had any other liver disease (such as acute hepatitis, exacerbation of chronic hepatitis), cirrhosis (Child B or C), or hepatocellular carcinoma. 3. Pregnant women or women who suspected of being pregnant. 4. Patients who attending physician judged as being inappropriate.

Design outcomes

Primary

MeasureTime frame
ALT

Secondary

MeasureTime frame
CBC biochemical test (gamma-GTP, LDL-C, HDL-C, TG, FBS, UA, IRI, HOMA-IR, Fe, Ferritin) Body fat measurement by CT Body measurement Body composition analysis

Countries

Japan

Contacts

Public ContactHideki Fujii

Osaka City Juso Hospital Department of Gastroenterology

fujiirola@yahoo.co.jp06-6150-8000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026